Hope Valley AI Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Hope Valley AI General Information
Description
Developer of oncology AI (artificial intelligence) research technologies designed to accelerate scientific discovery through risk-informed modeling of rare health events. The company offers frontier AI laboratories, uncertainty quantification, multi-physics foundation models, and end-to-end research orchestration tools, enabling researchers to improve early risk detection, validate innovations, and advance digital prevention in oncology.
Contact Information
Website
www.hopevalleylabs.aiCorporate Office
- 21 Chemin du Prieuré Cedex 1
- 17000 La Rochelle
- France
Corporate Office
- 21 Chemin du Prieuré Cedex 1
- 17000 La Rochelle
- France
Hope Valley AI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Hope Valley AI Patents
Hope Valley AI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026185471-A1 | Ai-assisted stochastic hybrid system, device and method for health and safety monitoring and capture of early weak signals of a rare event for a patient | Pending | 07-Mar-2025 | ||
| EP-4804207-A1 | Ai-assisted stochastic hybrid system, device and method for health and safety monitoring and capture of early weak signals of a rare event in a patient | Pending | 07-Mar-2025 | ||
| FR-3171115-A1 | Ai-based system, device and method for cancer risk prediction and multi-detection of early low signals of cancer incubation and rare events in a patient | Pending | 03-Jan-2025 | ||
| WO-2026146176-A1 | Ai-based system, device and method for predicting a multi-cancer risk and detecting early weak signals of developing cancer and rare events in a patient | Pending | 03-Jan-2025 | ||
| WO-2026146175-A1 | Ai-based system, device and method for predicting a risk and detecting early weak signals of developing a breast cancer or a recurrent breast cancer in a patient | Pending | 03-Jan-2025 | G16H20/40 |
Hope Valley AI Signals
Hope Valley AI Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 212Founders | Accelerator/Incubator | Minority | ||
| ATLAS Technopole | Accelerator/Incubator |
Hope Valley AI FAQs
-
When was Hope Valley AI founded?
Hope Valley AI was founded in 2024.
-
Where is Hope Valley AI headquartered?
Hope Valley AI is headquartered in La Rochelle, France.
-
What is the size of Hope Valley AI?
Hope Valley AI has 4 total employees.
-
What industry is Hope Valley AI in?
Hope Valley AI’s primary industry is Other Healthcare Technology Systems.
-
Is Hope Valley AI a private or public company?
Hope Valley AI is a Private company.
-
What is Hope Valley AI’s current revenue?
The current revenue for Hope Valley AI is .
-
Who are Hope Valley AI’s investors?
212Founders and ATLAS Technopole have invested in Hope Valley AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process